Product information and disease descriptionPlace of product in therapyDisease description
Definition and etiology
12 evidence topics · 7 sources
Definition of non-muscle-invasive bladder cancer
Definition and clinical classification of carcinoma in situ
High-risk and very high-risk NMIBC: EAU prognostic factor risk groups
Definition of BCG-unresponsive disease: FDA guidance
Categories of BCG failure: EAU definitions
BCG-exposed disease: high-grade recurrence outside the BCG-unresponsive criteria
International Bladder Cancer Group classification of BCG failures
“Table 5 summarizes our classification of BCG failures, dividing them into the following four types: BCG refractory, BCG relapsing, BCG intolerant, and BCG unresponsive.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Persistent high-grade disease at 6 months despite adequate BCG” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The term BCG unresponsive, which essentially includes BCG refractory and BCG relapsing (within 6 months of last BCG exposure), is meant to denote a subgroup of patients at highest risk of recurrence and progression for whom additional BCG therapy is not a feasible option.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“For clinical trials, adequate BCG therapy is when a patient has received at least five of six induction instillations and at least one maintenance (two of three instillations) in a 6-month period.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Origin of the term BCG-unresponsive: 2015 Genitourinary Cancers Symposium task force
“identifies those patients with high grade (HG) NMIBC who have been treated with adequate BCG (see below) and are unlikely to benefit from and should not receive further intravesical BCG.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Have received at least 2 courses of intravesical BCG – defined as at least 5 of 6 induction instillations of BCG and at least 2 of 3 instillations of maintenance BCG.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Exception: those who have T1HG disease at first evaluation following induction BCG alone (at least 5 of 6 doses) would qualify.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“We also recommend including CIS of the prostatic urethra within the definition of BCG unresponsive” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Data-driven definition of BCG-unresponsive disease
“Those with CIS recurrence at 6–12 months did not differ from those recurring within 6 months (HR = 0.88, p = 0.71).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Patients who fail two courses of BCG with either persistent or recurrent multifocal papillary disease within 6 months or CIS within 12 months of their prior BCG should be considered BCG unresponsive.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote